Used as a key intermediate in the synthesis of kinase inhibitors, particularly in the development of anticancer agents. Its structure allows for selective modification to enhance binding affinity to specific enzyme targets. Commonly employed in medicinal chemistry for constructing pyrrolopyrimidine-based scaffolds, which are found in drugs targeting signaling pathways involved in tumor growth and inflammation. Also utilized in research settings to develop new pharmaceuticals with improved metabolic stability and bioavailability.